Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795975 · ClinicalTrials.gov registry record
Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples
A clinical trial, sponsored by Hologic.
- Terminated
- Registry status
- 1,766
- Enrollment target
NCT02795975: Clinical Trial study, sponsored by Hologic.
NCT02795975 is a clinical trial that was terminated before completion, run by Hologic. The registered enrollment target is 1,766 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02795975 was terminated before completion, sponsored by Hologic.
- TERMINATED
- Registry status
- 1,766 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,766 participants |
| Start Date | 2016-06-30 |
| Est. Completion | 2017-03-01 |
Why NCT02795975 stopped before completion
NCT02795975 is an observational study that tracks outcomes without assigning an intervention. Its 1,766 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02795975 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02795975 about?
NCT02795975 is a clinical study titled "Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples". The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.
What is the current status of trial NCT02795975?
This trial is currently terminated. The enrollment target is 1,766 participants. The study started on 2016-06-30. Estimated completion is 2017-03-01.
Who is sponsoring clinical trial NCT02795975?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06239688 · 1,764 participants · NA
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
- NCT06872892 · 1,755 participants · Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- NCT07062172 · 1,753 participants · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI